Effect of cytokine hemoadsorption on brain death-induced ventricular dysfunction in a porcine model.
J. Thorac. Cardiovasc. Surg., Nov (2012)
Teaching behaviors in the cardiac surgery simulation environment.
J. Thorac. Cardiovasc. Surg., Oct (2012)
Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users.
Ann. Thorac. Surg., Jan;93(1):51-7 (2012)
Mitral regurgitation--what is best for my patient?
N. Engl. J. Med., Apr;364(15):1462-3 (2011)
Management of acute regurgitation in left-sided cardiac valves.
Tex Heart Inst J., 38(1):9-19 (2011)
Joint Council on Thoracic Surgical Education: an investment in our future.
J. Thorac. Cardiovasc. Surg., Feb;141(2):318-21 (2011)
Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials.
J. Thorac. Cardiovasc. Surg., Jul;142(1):89-98 (2011)
Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.
Arterioscler. Thromb. Vasc. Biol., Nov;30(11):2136-42 (2010)
Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement.
J. Heart Lung Transplant., Sep;29(9):1021-5 (2010)
Consensus statement: minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass.
Heart Surg Forum., Apr;13(2):E116-23 (2010)
Acute valvular regurgitation.
Circulation., Jun;119(25):3232-41 (2009)
Consensus statement: Defining minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass.
Heart Surg Forum., 11(5):E316-22 (2008)
Characteristics of extracoronary vascular disease in heart transplant recipient.
J Card Surg., 23(5):459-63 (2008 Sep-Oct)
Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy.
Circulation., Nov;116(20):2298-306 (2007)
Translational research: is there a future?
J. Thorac. Cardiovasc. Surg., Jun;133(6):1409-11 (2007)
Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization.
Crit. Care Med., May;35(5):1296-301 (2007)
Is pre-transplant vascular disease a risk factor for mortality and morbidity after heart transplantation?
Eur J Cardiothorac Surg., Mar;31(3):457-61 (2007)
Open-chest management after heart transplantation.
Tex Heart Inst J., 33(3):306-9 (2006)
Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview.
Am. Heart J., Aug;152(2):291-6 (2006)
Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients.
Ann. Thorac. Surg., Aug;82(2):486-92 (2006)